Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZT-501 for prevention of ibuprofen-associated ulcers (REDUCE-2)
NCT00450658Phase 3Completed
- Sponsor
- Amgen
- Start
- Mar 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ibuprofen + famotidine in peptic ulcer disease (PUD), sponsored by Amgen. Started Mar 2007; status: completed.
02
Drugs
ibuprofen + famotidine
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT00450658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450658.